Clinical Trial Update: Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluated cardiovascular outcomes in patients with type 2 diabetes after an acute coronary syndrome while treated with lixisenatide. Re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Type 2 Diabetes Mellitus

Drugs mentioned

• Lixisenatide (lixisenatide)

Snippet

Sponsor: Sanofi | Conditions: Acute Coronary Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2016-10-14